Not applicableStudy completedNCT00948883What this trial is testingStudy of Cancers After Solid Organs TransplantsWho this might be right forCancerOrgan Transplantation Assistance Publique - Hôpitaux de Paris 330
Early research (Phase 1)Study completedNCT00990717What this trial is testingSafety Study Looking at the Use of a Natural Killer Cell Line Against Hematological MalignanciesWho this might be right forLeukemiaLymphomaMyeloma+1 more University Health Network, Toronto 8
Not applicableStudy completedNCT00333190What this trial is testingCD8+ T Cell Depletion for GVHD Prophylaxis After Peripheral Blood Stem Cell TransplantationWho this might be right forHematologic MalignancyAMLALL+4 more Dana-Farber Cancer Institute 30
Testing effectiveness (Phase 2)WithdrawnNCT04334174What this trial is testingStudy of Brentuximab Vedotin as Therapy After Autologous Stem Cell Transplant in Cluster of Differentiation Antigen 30 (CD30) Positive Peripheral TCell LymphomasWho this might be right forT Cell Lymphoma University of Kansas Medical Center
Testing effectiveness (Phase 2)Ended earlyNCT01343368What this trial is testingPreservation of Ovarian Function After Hematopoietic Cell TransplantWho this might be right forMultiple MyelomaNon-Hodgkin LymphomaHodgkin Disease+2 more Masonic Cancer Center, University of Minnesota 19
Not applicableUnknownNCT06075212What this trial is testingImmune Reconstitution After Allo-HSCT and BlinatumomabWho this might be right forLeukemia, Lymphoid Sichuan University 20
Early research (Phase 1)Study completedNCT01231919What this trial is testingMK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or LeukemiaWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAcute Leukemias of Ambiguous LineageAcute Myeloid Leukemia/Transient Myeloproliferative Disorder+48 more National Cancer Institute (NCI) 45
Early research (Phase 1)Ended earlyNCT03588936What this trial is testingNivolumab and Tocilizumab for Relapsed Hematological Malignancy Post-allogeneic TransplantWho this might be right forAcute LeukemiaChronic LeukemiaLymphoma+1 more Medical College of Wisconsin 2
Testing effectiveness (Phase 2)Active Not RecruitingNCT05393804What this trial is testingWhether Ide-cel (bb2121) Can Be Made From People With Multiple Myeloma Who Have Had a Hematopoietic Cell TransplantWho this might be right forMultiple Myeloma Memorial Sloan Kettering Cancer Center 24
Early research (Phase 1)Ended earlyNCT00943293What this trial is testingMinor Histocompatibility Vaccination After Allogeneic Stem Cell Transplantation for Advanced Hematologic MalignanciesWho this might be right forPreleukemiaMyeloproliferative DisordersLymphoma+2 more University of Chicago 1
Not applicableNot Yet RecruitingNCT07605884What this trial is testingDenys-Drash Syndrome and Risk of Post-transplant Lymphoproliferative DisorderWho this might be right forDenys-Drash Syndrome Assistance Publique - Hôpitaux de Paris 108
Testing effectiveness (Phase 2)Study completedNCT03317899What this trial is testingStem Cell Transplant With or Without Tbo-filgrastim in Treating Patients With Multiple Myeloma or Non-Hodgkin LymphomaWho this might be right forNon-Hodgkin's LymphomaPlasma Cell Myeloma Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 77
Large-scale testing (Phase 3)Ended earlyNCT01749111What this trial is testingComparison Between Cyclophosphamide and Combination of Methotrexate + Calcineurin Inhibitor for GVHD ProphylaxisWho this might be right forAcute Myelogenous LeukemiaAcute Lymphoid LeukemiaMyeloproliferative Disease+3 more Hospital Israelita Albert Einstein 3
Large-scale testing (Phase 3)UnknownNCT01316744What this trial is testingKetamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic PainWho this might be right forCancer University of Glasgow 214
Not applicableStudy completedNCT00167167What this trial is testingDonor Lymphocyte Infusion (DLI) for Relapsed (Post Transplant) LeukemiaWho this might be right forLeukemia, Myeloid, ChronicAMLMDS+1 more Masonic Cancer Center, University of Minnesota 40
Testing effectiveness (Phase 2)Study completedNCT00867529What this trial is testingRituximab in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant for Relapsed or Refractory B-cell LymphomaWho this might be right forB-cell Adult Acute Lymphoblastic LeukemiaB-cell Childhood Acute Lymphoblastic LeukemiaB-cell Chronic Lymphocytic Leukemia+35 more Fred Hutchinson Cancer Center 63
Early research (Phase 1)Study completedNCT02996773What this trial is testingHaploidentical BMT With Post-Transplant Cyclophosphamide and BendamustineWho this might be right forAcute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaMyelodysplastic Syndromes+10 more University of Arizona 50
Testing effectiveness (Phase 2)Looking for participantsNCT06815003What this trial is testingVedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity ConditioningWho this might be right forAcute Lymphoblastic LeukemiaAcute Myeloid LeukemiaChronic Myelomonocytic Leukemia+3 more City of Hope Medical Center 35
Testing effectiveness (Phase 2)Study completedNCT00006251What this trial is testingFludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic CancerWho this might be right forAcute Undifferentiated LeukemiaAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell Lymphoma+61 more Fred Hutchinson Cancer Center 21
Early research (Phase 1)Study completedNCT01342289What this trial is testingShorter Course Tacrolimus After Nonmyeloablative, Related Donor BMT With High-dose Posttransplantation CyclophosphamideWho this might be right forHodgkin's LymphomaLeukemiaMyelodysplastic Syndrome(MDS)+2 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 127